Insights into Local Tumor Microenvironment Immune Factors Associated with Regression of Cutaneous Melanoma Metastases by Mycobacterium bovis Bacille Calmette–Guérin

Dual Faces of IFN  in Cancer Progression: A Role of PD-L1 Induction in the Determination of Pro- and Antitumor Immunity

(2016) M. Mandai et al.   CLINICAL CANCER RESEARCH

Proportions of blood-borne Vδ1+ and Vδ2+ T-cells are associated with overall survival of melanoma patients treated with ipilimumab

(2016) Kilian Wistuba-Hamprecht et al.   EUROPEAN JOURNAL OF CANCER

The Emerging Protumor Role of    T Lymphocytes: Implications for Cancer Immunotherapy

(2015) M. Rei et al.   CANCER RESEARCH

Activation of Human γδ T Cells by Cytosolic Interactions of BTN3A1 with Soluble Phosphoantigens and the Cytoskeletal Adaptor Periplakin

(2015) David A. Rhodes et al.   JOURNAL OF IMMUNOLOGY

Nivolumab in Previously Untreated Melanoma without BRAF Mutation

(2015) Caroline Robert et al.   NEW ENGLAND JOURNAL OF MEDICINE

Nivolumab in melanoma: latest evidence and clinical potential

(2015) Douglas B. Johnson et al.   Therapeutic Advances in Medical Oncology

Molecules and Mechanisms Implicated in the Peculiar Antigenic Activation Process of Human Vγ9Vδ2 T Cells

(2015) Christelle Harly et al.   Frontiers in Immunology

γδ T Cells in HIV Disease: Past, Present, and Future

(2015) C. David Pauza et al.   Frontiers in Immunology

Chemokines and Chemokine Receptors: Positioning Cells for Host Defense and Immunity

(2014) Jason W. Griffith et al.   Annual Review of Immunology

Tumor-induced perturbations of cytokines and immune cell networks

(2014) Brett Burkholder et al.   BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER

Targeted Activation of Human Vγ9Vδ2-T Cells Controls Epstein-Barr Virus-Induced B Cell Lymphoproliferative Disease

(2014) Zheng Xiang et al.   CANCER CELL

γδ T Cells and Their Potential for Immunotherapy

(2014) Yan-Ling Wu et al.   International Journal of Biological Sciences

The mechanism of action of BCG therapy for bladder cancer—a current perspective

(2014) Gil Redelman-Sidi et al.   Nature Reviews Urology

IL-32 is a molecular marker of a host defense network in human tuberculosis

(2014) D. Montoya et al.   Science Translational Medicine

The role of gamma delta T cells in immunity to Mycobacterium bovis infection in cattle

(2014) Jodi L. McGill et al.   VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY

Chronic Inflammation and Cytokines in the Tumor Microenvironment

(2014) Glauben Landskron et al.   Journal of Immunology Research

Plasticity of γδ T Cells: Impact on the Anti-Tumor Response

(2014) Virginie Lafont et al.   Frontiers in Immunology

Human housekeeping genes, revisited

(2013) Eli Eisenberg et al.   TRENDS IN GENETICS

Interleukin-18 and IL-18 Binding Protein

(2013) Charles A. Dinarello et al.   Frontiers in Immunology

Diversity of γδ T-cell antigens

(2012) Willi K Born et al.   Cellular & Molecular Immunology

Multifunctional immune responses of HMBPP-specific Vγ2Vδ2 T cells in M. tuberculosis and other infections

(2012) Zheng W Chen   Cellular & Molecular Immunology

Aggregation-enhanced emission and efficient electroluminescence of tetraphenylethene-cored luminogens

(2012) Zhengfeng Chang et al.   CHEMICAL COMMUNICATIONS

Preexisting BCG-Specific T Cells Improve Intravesical Immunotherapy for Bladder Cancer

(2012) C. Biot et al.   Science Translational Medicine

Harnessing γδ T cells in anticancer immunotherapy

(2012) Dalil Hannani et al.   TRENDS IN IMMUNOLOGY

The natural and the inducible: interleukin (IL)-17-producing γδ T cells

(2012) Yueh-hsiu Chien et al.   TRENDS IN IMMUNOLOGY

The pro- and anti-inflammatory properties of the cytokine interleukin-6

(2011) Jürgen Scheller et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome

(2011) Bo Li et al.   BMC BIOINFORMATICS

γδ T-cells: cross-talk between innate and adaptive immunity

(2011) Dieter Kabelitz   CELLULAR AND MOLECULAR LIFE SCIENCES

Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma

(2011) Caroline Robert et al.   NEW ENGLAND JOURNAL OF MEDICINE

Targeting    T Lymphocytes for Cancer Immunotherapy: From Novel Mechanistic Insight to Clinical Application

(2010) A. Q. Gomes et al.   CANCER RESEARCH

V 9V 2 T Lymphocytes Efficiently Recognize and Kill Zoledronate-Sensitized, Imatinib-Sensitive, and Imatinib-Resistant Chronic Myelogenous Leukemia Cells

(2010) M. D'Asaro et al.   JOURNAL OF IMMUNOLOGY

Bromohydrin Pyrophosphate-stimulated Vγ9δ2 T Cells Expanded Ex Vivo From Patients With Poor-Prognosis Neuroblastoma Lyse Autologous Primary Tumor Cells

(2010) Jamel Chargui et al.   JOURNAL OF IMMUNOTHERAPY

Bromohydrin pyrophosphate enhances antibody-dependent cell-mediated cytotoxicity induced by therapeutic antibodies

(2009) J. Gertner-Dardenne et al.   BLOOD

Dynamic Development of Homing Receptor Expression and Memory Cell Differentiation of Infant CD4+CD25high Regulatory T Cells

(2009) H. Grindebacke et al.   JOURNAL OF IMMUNOLOGY

Efficient Killing of Human Colon Cancer Stem Cells by    T Lymphocytes

(2009) M. Todaro et al.   JOURNAL OF IMMUNOLOGY

The Interleukin-8 Pathway in Cancer

(2008) D. J.J. Waugh et al.   CLINICAL CANCER RESEARCH

Dysregulation of the host mevalonate pathway during early bacterial infection activates human TCR γδ cells

(2008) Magdalena Kistowska et al.   EUROPEAN JOURNAL OF IMMUNOLOGY